Mitoxantrone, prednisone, pentostatin and bleomycin for patients with indolent non-Hodgkin's lymphoma relapsed or unresponsive to previous treatments. Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (GISL)
Massimo Federico(University of Modena and Reggio Emilia), Maura Brugiatelli(Azienda Ospedaliera Ospedali Riuniti Papardo Piemonte), A Bagnulo, Maria Angela Sirotti, Matteo Dell’Olio(Casa Sollievo della Sofferenza), Nicola Di Renzo(Presidio Ospedaliero), Giovanni Santacroce(Università Cattolica del Sacro Cuore), Mario Petrini(University of Pisa), Romano Danesi(University of Milan), Mario Del Tacca, Antonella Montanini, Vincenzo Callea(Azienda Ospedaliero Universitaria San Giovanni Battista)
IRIS UNIMORE (University of Modena and Reggio Emilia)
January 1, 2003
Cited by 2
Related Papers
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Rechallenge for Patients With <i>RAS</i> and <i>BRAF</i> Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
|JAMA Oncology|2018|418
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial
|Journal of Clinical Oncology|2016|394
Decline with age of the respiratory chain activity in human skeletal muscle
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|1994|340